ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

COLL Collegium Pharmaceutical Inc

32.59
0.75 (2.36%)
25 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Collegium Pharmaceutical Inc NASDAQ:COLL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.75 2.36% 32.59 27.77 37.90 32.755 31.73 31.73 443,788 05:00:02

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

24/10/2024 1:00pm

GlobeNewswire Inc.


Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart


From Jul 2024 to Jan 2025

Click Here for more Collegium Pharmaceutical Charts.

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report third quarter 2024 financial results after the market closes on Thursday, November 7, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.

Conference Call Information To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q3 2024 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contact: Danielle Jesse                                                                                        Director, Investor Relationsir@collegiumpharma.com

Media Contact:Marissa SamuelsVice President, Corporate Communicationscommunications@collegiumpharma.com 

1 Year Collegium Pharmaceutical Chart

1 Year Collegium Pharmaceutical Chart

1 Month Collegium Pharmaceutical Chart

1 Month Collegium Pharmaceutical Chart